Why Am I Still Waiting to Get Covid-19 Antibody Testing?

Why Am I Still Waiting to Get Covid-19 Antibody Testing?

First, Happy Mother’s Day to All Amazing Women! Wishing you to be healthy and happy!

This week I was asked a lot about antibody testing and some of my clients and friends already tested with positive and negative antibody results. And we do know, or at least we think we know, that around 20% of those who had the virus do not develop antibodies according to Lancet. That is 2 out of 10 will not show positive antibodies. Can those people get sick with it again? The answer is “we don’t know”. You probably heard a lot of “we do not know” from the healthcare practitioners. Please, be patient, there is a lot of research going on.

What testing options do we currently have:

1. Oral and Nasopharyngeal (NP): Testing is done to identify COVID-19 real-time polymerase chain reaction (RT-PCR) technology to detect the presence of SARS-CoV-2 in respiratory samples. This test is currently available only to hospitals and public health institutions and uses RT-PCR technology to id SARS-CoV-2 using a nasopharyngeal (NP) or oral swab.
2. Blood and Plasma: The COVID-19 Antibody Test is a simple blood test that uses superior ELISA technology to detect the qualitative presence of the human Immunoglobulin M (IgM) and Immunoglobulin G (IgG) antibodies that bind to the SARS-CoV-2 virus (the novel virus that causes COVID-19). The test can be used in both symptomatic and asymptomatic patients – making it a useful tool in identifying patients who have been exposed to COVID-19. The COVID-19 IgG/IgM Antibody Test is a critical tool in helping practitioners understand the trajectory of the SARS-CoV-2 virus and its spread. The Role of IgG and IgM Antibody Testing in COVID-19IgG and IgM antibodies indicate two different stages of the immune response to the COVID-19 virus. Understanding the IgG/IgM response to SARS-CoV-2 can help practitioners identify patient exposure to SARS-CoV-2 and determine whether patients may have developed levels of immunity to it. IgG and IgM antibodies both play key roles in the progression and management of COVID-19.
   • IgM antibodies are typically detected earlier in the course of an infection than IgG antibodies. Studies published to date indicate that IgM antibodies to SARS-CoV-2 are usually detected within the first week after symptom onset, peak within 3 to 4 weeks, and then begin to decline.
   • IgG antibodies to SARS-CoV-2 are often detected after the first week of symptom onset. Although the longer-term trends for IgG antibodies in COVID-19 have not yet been established, previous studies in SARS indicated that IgG antibodies peaked within a few months after symptom onset, and gradually declined thereafter.
3. Coronavirus Stool Test/Screening and Surveillance. Coronavirus stool tests can help practitioners screen for SARS-CoV-2 and monitor and surveil patients who have tested positive for the disease.

Research from around the world indicates that as many as 50 percent of patients who are positive for SARS-CoV-2 experience gastrointestinal complaints.

Furthermore, evidence suggests SARS-CoV-2 is detectable in stool and its presence in stool may last for up to five weeks after clearance from the respiratory tract. A recent article published in Lancet states:

“Our data suggest the possibility of extended duration of viral shedding in faeces, for nearly 5 weeks after the patients’ respiratory samples tested negative for SARS-CoV-2 RNA. Although knowledge about the viability of SARS-CoV-2 is limited, the virus could remain viable in the environment for days, which could lead to faecal-oral transmission, as seen with severe acute respiratory virus CoV and Middle East respiratory syndrome CoV. Therefore, routine stool sample testing with real-time RT-PCR is highly recommended after the clearance of viral RNA in a patient’s respiratory samples. Strict precautions to prevent transmission should be taken for patients who are in hospital or self-quarantined if their faecal samples test positive.”

The following are those patients who can benefit from stool testing:

• Patients exhibiting signs and symptoms of SARS-CoV-2, including:
  • Fever
  • Cough
  • Shortness of breath
  • Gastrointestinal Complaints
• Asymptomatic Patients Concerned about Having or Transmitting the Virus
• Surveillance of patients who previously tested positive for COVID-19 by respiratory sample

Although I think I might have had Covid-19 sometime in February and I would love to be sure if I developed the antibodies, I am still looking into the most reliable COVID-19 panel that is highly sensitive and accurate assay for viral antibodies. I am yet to see convincing data. I think I’m getting close to picking one particular functional diagnostic lab but will still verify some more data before I jump in and will make recommendations to you, my amazing tribe. Sit tight, I will be updating you soon.

Most of the supplement deliveries are business as usual now. I am now using a different dispensary called FullScript.They seem to handle things quickly and they ship with 2 days shipping. Just click HERE to REGISTER and ORDER. ALL the supplements mentioned above are also available through FullScript.

Or you can simply send the orders via email to us, this way it will be addressed in the timely manner.

We restocked on:

• Vitamin C
• Vitamin D
• Zinc
• Quercetin
• Liver Support Supplements
• Gut Support Supplements
• Adrenal Support Supplements
• Immune Support Supplements

Simply reply via email and we will send you the products that you need ASAP. If you’ve ordered and waited for weeks, you have an option to cancel with those websites, just thought you wanted to know. 

Sending LOVE,

Dr. Inna